Revenue
EPS
EBIT
No Data
BrightPath Biotherapeutics: Notice regarding revisions to earnings forecasts
Mar 24 05:00 ET
BrightPath Biotherapeutics: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Feb 14 01:30 ET
BrightPath Biotherapeutics: Confirmation letter
Nov 8, 2024 01:35 ET
BrightPath Biotherapeutics: Half Year Report - Term 22 (2024/04/01 - 2025/03/31)
Nov 8, 2024 01:34 ET
Read more